“lymphoma” Archives

in
Entry Author Date Location
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Incyte Commits $900M to MorphoSys for Rights to Lymphoma Drug 01/13/20 National
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal 12/03/19 San Francisco
SeaGen to Seek FDA Nod After Breast Cancer Drug Hits Goals of Key Study 10/21/19 Seattle
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Elanco Bolsters Pet Products Pipeline With $234M Deal for Aratana 04/26/19 Indiana
Merck Scooping Up Cancer Drug Developer Immune Design for $300M 02/21/19 New York
ASH 2018: Three Up, Two Down as Big Blood Disease Meeting Rolls On 12/03/18 National
Bio Roundup: CRISPR Babies, Blood Diseases, Big Cancer Nod & More 11/30/18 National
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
CTI BioPharma’s Non-Hodgkin Lymphoma Drug Fails Study, Shares Sink 07/09/18 Seattle
FDA Pumps the Brakes on Epizyme’s Top Cancer Drug Tazemetostat 04/23/18 Boston
Surface Oncology’s Upsized IPO Reels In $108M for Lead Cancer Drug 04/18/18 Boston
Bio Roundup: Tax Cuts, a Funding Rush, Hemophilia Questions & More 12/15/17 National
At Seattle Children’s, Another Piece of Ambitious CAR-T Plan in Place 11/16/17 Seattle
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More 11/03/17 National
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell Therapy 08/28/17 San Francisco
Keeping Focus on Cancer, Karyopharm Licenses Antiviral to Anivive 05/04/17 Boston
New Bain Investor Yumin Choi on Obamacare’s Future, Surviving Cancer 01/09/17 Boston
Kite Unveils Anticipated CAR-T Cancer Data: Positive But Not Complete 09/26/16 National
Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More 09/02/16 National
MiRagen Lands $41M for MicroRNA Drugs in Cancer, Fibrosis 11/10/15 Boulder/Denver
Constellation Pharma Plots IPO Run As Genentech Passes on Buyout Deal 08/24/15 Boston
After Celgene Deal, Juno Revs Armored CAR For Ovarian Cancer Trial 07/10/15 Seattle
With Celiac Deal, Celimmune Aims to Give New Life to Old Amgen Drug 03/02/15 New York
Houston’s Bellicum Pharma Rides T-Cell Therapy Wave to $140M IPO 12/18/14 Texas
Page 1 of 2 next page »